Sat, Aug 2, 2014, 2:37 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Facebook, Inc. (FB) Message Board

  • wcoastguy2008 wcoastguy2008 Oct 31, 2012 10:53 AM Flag

    Copnsider Investing In Mannkind - MNKD - Currently Under $2.00

    Mannkind (MNKD) has the next potential blockbuster drug to treat diabetes, Afrezza.

    Currently in phase 3 trials.

    Recently secured funding through approval has created a buying opportunity.

    The company's billionaire C.E.O., Al Mann, has invested over a billion dollars in the company.

    A "big pharma" partnership could happen at any time as the company has stated that it's currently in talks with several potential candidates.

    Mannkind will be one of the top performing stocks over the next 12 months.

    Due diligence.
    1 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Re: Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By wcoastguy2008 . Oct 26, 2012 11:01 AM . Permalink Go to topic

    Mannkind will be up 200-300% over the next 12 months as it moves towards an F.D.A. decision. Do you really think ARNA will be anywhere close to that?
    0 users liked this posts 0 users disliked this posts
    Reply
    Re: Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By thearizonacardinals . Oct 26, 2012 8:50 AM . Permalink Go to topic

    Thanks for bumping his post keith
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Re: Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By wcoastguy2008 . Oct 26, 2012 8:49 AM . Permalink Go to topic

    200-300% upside over the next 12 months. :)
    0 users liked this posts 0 users disliked this posts
    Reply
    Re: Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By aunttizzy . Oct 25, 2012 2:57 PM . Permalink Go to topic

    Mannkind will easily outperform ARNA over the next 12 months. It will be no contest.
    1 users liked this posts 1 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By keithwilliams2315 . Oct 25, 2012 9:00 AM . Permalink Go to topic

    Buzzard!!!!! Get off this M.B.
    1 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By sharonconl . Oct 25, 2012 8:54 AM . Permalink Go to topic

    Thanks, putting you on ignore.
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Mannkind - MNKD - Buy A Few Shares Under $2.00 for The Approval Run
    By aunttizzy . Oct 25, 2012 8:49 AM . Permalink

    One company to consider adding to your watch list is Mannkind, MNKD. Upgraded to "market outperform" at Motley Fool yesterday.

    Company has secured financing to operate through Afrezza's approval. A big pharma partnership could happen at any time.

    At under $2.00 a share currently now may be a good time to add a few shares to your portfolio for the approval run-up.
    2 users liked this posts 2 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: OT - thinking about MNKD
    By jmontana0629 . Oct 23, 2012 1:52 PM . Permalink Go to topic

    With the anemic corporate numbers and pending major correction of the market in general in an election year and MNKD's catalyst months away, i would wait till 1.60s. Not to mention some will take losses to offset their gains before end of the year and that will also not help with pps run up anytime soon.
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    OT - thinking about MNKD
    By cycincy . Oct 23, 2012 1:48 PM . Permalink

    thoughts on MannKind... My buy in price was 1.75, but I am not sure it is gonna make it that low.

    Wait, or pull the trigger at 1.84?

    Sentiment: Hold
    1 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By wcoastguy2008 . Oct 23, 2012 8:52 AM . Permalink Go to topic

    Third quarter conference call on 10/29.

    Higher before then.
    0 users liked this posts 0 users disliked this posts
    Reply
    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By wcoastguy2008 . Oct 22, 2012 2:18 PM . Permalink

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.
    0 users liked this posts 0 users disliked this posts
    Reply
    Re: Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By aunttizzy . Oct 22, 2012 10:29 AM . Permalink Go to topic

    Potential blockbuster drug.
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: OT:mnkd
    By kitesurfingspike . Oct 22, 2012 9:08 AM . Permalink Go to topic

    mnkd looking good.

    Sentiment: Buy
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By wcoastguy2008 . Oct 22, 2012 8:21 AM . Permalink

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.
    0 users liked this posts 0 users disliked this posts
    Reply
    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By wcoastguy2008 . Oct 22, 2012 8:21 AM . Permalink

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.
    0 users liked this posts 1 users disliked this posts
    Reply
    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By wcoastguy2008 . Oct 22, 2012 8:21 AM . Permalink

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.
    0 users liked this posts 0 users disliked this posts
    Reply
    Mannkind - MNKD - Consider Buying A Few Shares Under $2.00
    By aunttizzy . Oct 21, 2012 9:55 AM . Permalink

    The announcement that Mannkind has issued a new secondary to raise funds has created a buying opportunity.

    Mannkind's insulin drug, Afrezza, could receive F.D.A. approval as early as September,2013 if it is granted "priority review" status.

    With $1.6 billion in tax-loss carry forwards and insulin inventory to produce $10,000,000,000 worth of Afrezza the company in a potential takeover target which may be why Mr. Mann probably decided to convert so much debt to equity at $2.59/share last week.

    A "big-pharma" partnership could happen at any time.

    Consider buying a few shares below $2.00 before the approval run-up begins.
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Re: Re: Re: Re: Why I don't own ARNA -- and probably shouldn't own VVUS either.
    By bearofbleecker . Oct 20, 2012 4:02 PM . Permalink Go to topic

    The market is telling you that many of the stocks I mentioned above have much brighter prospects. Nothing is more dangerous in investing than the need to be proven right. If you can buy a stock like PCYC on sale Friday, which has gone from 10.83 to 62.24 over the past year,why would you buy a stock like MNKD which has gone from 2.56 to 1.98 over the same period?
    0 users liked this posts 3 users disliked this posts
    Ignore User
    |
    Report Abuse
    Re: Re: Re: Re: Why I don't own ARNA -- and probably shouldn't own VVUS either.
    By johndaly123 . Oct 20, 2012 3:39 PM . Permalink Go to topic

    arna has a future bright with positive catalysts. I have been doing other things besides waiting here, I doubled on srpt the other day should have sold higher, but wth! bought some mnkd @1.96, good entry point.
    I can sell my arna for 20 in a few months, why settle for 9 now? unless you have some other stock with as much future potential over the next year(please do tell!).

    Sentiment: Buy
    2 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: I love you longs
    By samuelraymond518 . Oct 19, 2012 12:15 PM . Permalink Go to topic

    Thoughts, hows this for action. I sold $514,000 in stocks when the dow was a 13,550 about 2 weeks ago. that included my MNKD at $2.96. The only stock I kept was 4800 shares of ARNA. That's it. the rest is all cash tucked away. This was the first time is my life (Im 50) I ever took it all off the table. I dont like what i see out there. I will put it all back to work but when I see some fixes to the crubling econimies of the world. regards, Sam

    Sentiment: Strong Buy
    1 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse
    Re: Mannkind - MNKD - On Sale Under $2.00 Today
    By ybajerk2007 . Oct 18, 2012 2:29 PM . Permalink Go to topic

    Bought some at $1.98.
    0 users liked this posts 0 users disliked this posts
    Reply
    Ignore User
    |
    Report Abuse

    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Next
    +10

    We are in the process of testing our new message boards. Please provide your feedback so that we can optimize the user experience.

 
FB
72.36-0.29(-0.40%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.